Health Highlights: Feb. 21, 2012

Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:

Nutritional Guidelines Planned for School
Vending Machines

Nutritional standards for vending machine products and other foods that
students can buy outside of school cafeterias are expected to be
introduced by the Obama administration within the next few weeks.

White House officials say students eat 19 percent to 50 percent of
their daily food at school and they want to ensure that what students eat
doesn’t harm their health or make them fat, The New York Times
reported.

Childhood obesity in the United States has more than tripled in the
past 30 years, and school vending machines stocked with items such as soft
drinks, potato chips and cookies have contributed to that problem,
nutritionists say.

No details of the proposed nutritional standards have been released,
but are likely to focus on reduced amounts of sugar, salt and fat,
according to health advocates and snack food and soft drink industry
representatives, The Times reported.

—–

Imported Drug Will Help Shortage of Cancer
Drug Doxil: FDA

A drug called Lipodox will be imported from India in order to offset
the shortage of the chemotherapy drug Doxil, the U.S. Food and Drug
Administration says.

Doxil — which is used to treat ovarian cancer, multiple myeloma and
AIDS-related Kaposi’s sarcoma — has been in short supply in the U.S.
since last June. There are no generic versions of the drug, USA
Today
reported.

The FDA was expected to announce Tuesday that it has reached an
agreement with Sun Pharma Global of India to temporarily import Lipodox.
The agency has previously inspected the company.

The deal with address the Doxil shortage “for the foreseeable future,”
the FDA’s Sandra Kweder told USA Today.

Doxil is one of 287 drugs that have been in short supply this year,
says the University of Utah’s Drug Information Service. There were 61
drugs in short supply in 2005, according to the FDA.

——

Inhalable Caffeine Product to be Reviewed by
FDA

The safety of an inhalable caffeine product called AeroShot will be
reviewed by the U.S. Food and Drug Administration. The agency will also
investigate whether the product can be labeled as a dietary
supplement.

Aeroshot is sold in lipstick-sized canisters. A person puts one end of
the canister in their mouth and inhales a fine powder that dissolves
almost instantly. Each container contains 100 milligrams of caffeine
powder, about equal to the amount in a large cup of coffee, the
Associated Press reported.

New York U.S. Sen. Charles Schumer asked the FDA to review the safety
and legality of Aeroshot, which went on sale late last month in New York
and Massachusetts. It’s also sold in France.

“I am worried about how a product like this impacts kids and teens, who
are particularly vulnerable to overusing a product that allows one to take
hit after hit after hit, in rapid succession,” Schumer said, the AP
reported.

AeroShot is safe and does not contain additives used to enhance the
caffeine effect in energy drinks, according to inventor David Edwards, a
Harvard biomedical engineering professor.

—–

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes